RATIONALE: Although chronic use of methamphetamine (METH) leads to long-lasting cognitive dysfunction in humans, there are few reports about an animal model that reflects METH-induced impairment of working memory. OBJECTIVES: In this study, we investigated the effect of repeated METH treatment on spatial working memory in rats. MATERIALS AND METHODS: Rats were repeatedly administered METH (2 mg/kg) once a day for 7 days, and their memory function was assessed with a delayed spatial win-shift task in a radial arm maze. The task consisted of two phases, a training phase and a test phase, separated by a delay. RESULTS: METH-treated animals showed an impairment of performance in the test phase when the delay time was increased from 5 to 30 min or longer. The effect of METH persisted for at least 14 days after the drug withdrawal. METH-induced impairment of working memory was reversed by clozapine (3 and 10 mg/kg, for 7 days), but not haloperidol (1 and 2 mg/kg, for 7 days). The improving effect of clozapine diminished 7 days after the withdrawal. Phosphorylated extracellular signal-regulated kinase1/2 (ERK1/2) levels were significantly increased in the hippocampus of saline-treated control rats from 5 to 60 min after the training phase. In contrast, hyperphosphorylation of ERK1/2 was abolished in the hippocampus of rats treated with METH. CONCLUSIONS: These findings suggest that repeated METH treatment induces impairment of working memory, which is associated with a dysfunctional ERK1/2 pathway in the hippocampus. Furthermore, clozapine may be effective for the treatment of METH-induced cognitive dysfunction.
RATIONALE: Although chronic use of methamphetamine (METH) leads to long-lasting cognitive dysfunction in humans, there are few reports about an animal model that reflects METH-induced impairment of working memory. OBJECTIVES: In this study, we investigated the effect of repeated METH treatment on spatial working memory in rats. MATERIALS AND METHODS:Rats were repeatedly administered METH (2 mg/kg) once a day for 7 days, and their memory function was assessed with a delayed spatial win-shift task in a radial arm maze. The task consisted of two phases, a training phase and a test phase, separated by a delay. RESULTS:METH-treated animals showed an impairment of performance in the test phase when the delay time was increased from 5 to 30 min or longer. The effect of METH persisted for at least 14 days after the drug withdrawal. METH-induced impairment of working memory was reversed by clozapine (3 and 10 mg/kg, for 7 days), but not haloperidol (1 and 2 mg/kg, for 7 days). The improving effect of clozapine diminished 7 days after the withdrawal. Phosphorylated extracellular signal-regulated kinase1/2 (ERK1/2) levels were significantly increased in the hippocampus of saline-treated control rats from 5 to 60 min after the training phase. In contrast, hyperphosphorylation of ERK1/2 was abolished in the hippocampus of rats treated with METH. CONCLUSIONS: These findings suggest that repeated METH treatment induces impairment of working memory, which is associated with a dysfunctional ERK1/2 pathway in the hippocampus. Furthermore, clozapine may be effective for the treatment of METH-induced cognitive dysfunction.
Authors: Monica M Marcus; Kent E Jardemark; Marie-Louise Wadenberg; Xavier Langlois; Peter Hertel; Torgny H Svensson Journal: Int J Neuropsychopharmacol Date: 2005-04-28 Impact factor: 5.176
Authors: Cinara L Gonçalves; Camila B Furlanetto; Samira S Valvassori; Daniela V Bavaresco; Roger B Varela; Josiane Budni; João Quevedo; Emilio L Streck Journal: Metab Brain Dis Date: 2014-09-14 Impact factor: 3.584
Authors: Alicia Izquierdo; Annabelle M Belcher; Lori Scott; Victor A Cazares; Jack Chen; Steven J O'Dell; Melissa Malvaez; Tiffany Wu; John F Marshall Journal: Neuropsychopharmacology Date: 2010-01 Impact factor: 7.853